Spectrum Advisory Services’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$1.34M Hold
21,009
0.53% 67
2015
Q4
$1.45M Sell
21,009
-1,000
-5% -$66.1K 0.58% 65
2015
Q3
$1.3M Sell
22,009
-2,977
-12% -$189K 0.54% 67
2015
Q2
$1.66M Sell
24,986
-3,400
-12% -$224K 0.63% 55
2015
Q1
$1.83M Sell
28,386
-875
-3% -$54.8K 0.65% 56
2014
Q4
$1.73M Hold
29,261
0.6% 55
2014
Q3
$1.5M Sell
29,261
-2,500
-8% -$125K 0.54% 64
2014
Q2
$1.54M Hold
31,761
0.53% 64
2014
Q1
$1.65M Hold
31,761
0.59% 57
2013
Q4
$1.69M Buy
31,761
+250
+0.8% +$12.7K 0.6% 56
2013
Q3
$1.46M Hold
31,511
0.56% 60
2013
Q2
$1.41M Buy
+31,511
New +$1.37M 0.57% 60

Other funds holding BMY

Spectrum Advisory Services's BMY Position: Q1 2016 in Review

Spectrum Advisory Services held its Bristol-Myers Squibb (BMY) position steady in Q1 2016 at 21,009 shares worth $1.34M. The position accounts for 0.53% of the portfolio, ranked #67.

Spectrum Advisory Services first reported a position in BMY in Q2 2013 and has held it in 12 quarters since. The position peaked at $1.83M in Q1 2015. 1,523 funds tracked by Wall St. Rank hold BMY as of Q1 2016.

  • Spectrum Advisory Services held 21,009 shares of Bristol-Myers Squibb worth $1.34M as of Q1 2016.
  • Spectrum Advisory Services left its Bristol-Myers Squibb share count unchanged in Q1 2016.
  • Bristol-Myers Squibb made up 0.53% of Spectrum Advisory Services's portfolio in Q1 2016, its #67 holding.
  • Spectrum Advisory Services first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 12 quarters since.
  • Spectrum Advisory Services's Bristol-Myers Squibb position peaked at $1.83M in Q1 2015.
  • 1,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2016.

Based on Spectrum Advisory Services's 13F filing for Q1 2016, filed 12 May 2016.